|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Engineering, research and development expenses | |||||
| Amortization of intangible assets | |||||
| Goodwill impairment | |||||
| Gain on termination of alliance agreement | |||||
| Operating income | |||||
| Interest expense | |||||
| Interest income | |||||
| Other expense, net | |||||
| Income before income tax expense (benefit) | |||||
| Income tax expense (benefit) | |||||
| Equity in net loss of affiliates | |||||
| Net income | |||||
| Basic net income per common share (in dollars per share) | |||||
| Diluted net income per common share (in dollars per share) | |||||
| Weighted average shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
